Donor Age and Outcomes After Unrelated Donor Transplantation in the Post-Transplant Cyclophosphamide Era
Time to read: 02:44
Source: JAMA Oncology
Feature
Text
LETO Study: The Genetic Question in Kidney Donation: APOL1 Variants Influence Long-Term Donor Kidney?
Time to read: 05:02. "A national US cohort study following Black living kidney donors for nearly two decades finds that those carrying APOL1 high-risk genotypes face more than double the risk of significant kidney function decline — raising the question of whether routine genetic testing should become standard practice in donor candidate evaluation.
Source: JAMA Internal Medicine
Text
Beyond Milan Criteria: Rethinking Risk Stratification for Hepatocellular Carcinoma After Liver Transplantation
Time to read: 03:45. Liver transplantation remains a curative option for selected patients with hepatocellular carcinoma (HCC), but recurrence remains a major challenge
Source: Journal of Clinical Medicine,
Text
Expedited Kidney Allocation: Growth, Earlier Diversion, and Clinical Outcomes
Time to read: 04:02 |Expedited (out-of-sequence) kidney allocation increased 17-fold between 2020 and 202. Are patient and graft survival comparable to standard allocation, supporting the clinical safety of this strategy for improving organ utilisation.
Source: JAMA Nephrology
Text
Expanding kidney donor pools: 'Africa First' study highlights the promise of controlled donation after circulatory death
Time to read:03:22. Controlled donation after circulatory death (DCD) offers a promising solution to address the growing kidney transplant demand in South Africa, with long-term outcomes comparable to international standards, despite the challenges involved.
Source: SAMJ
Text
